Trunome
Liquid-biopsy diagnostics
Chennai clinical genomics startup (Acrannolife Genomics) offering non-invasive cell-free DNA blood tests to detect and monitor chronic disease and transplant health.
FoundersAgragesh Ramani & Avinash Ramani
Pitch & term sheet
Shark Tank India Season 2 · Episode 41 · Aired 27 Feb 2023 · Pitch #131
PitchedLiquid-biopsy chronic disease tests
Trunome pitched cell-free DNA blood tests for chronic disease monitoring. After separate offers from three sharks, four sharks combined on a single offer that the founders accepted.
Founders' ask
₹1.5 Cr
for 1% equity
Deal accepted on air
₹1.5 Cr
₹1.5 Cr for 2%
Implied valuation
₹75 Cr
Deal terms (ask implied ₹150 Cr)
Implied valuation is calculated by PitchBase Global as cash ÷ equity share and excludes debt. An offer accepted on television is subject to due diligence and may change or not close.
Sharks on the panel
Documented offers
- Revised
₹1.5 Cr for 2%
- Revised
₹1.5 Cr for 1.75%
- Revised
₹75 L for 1% + ₹75 L debt at 0% + Debt described as interest-free.
- Accepted on air
4.Aman Gupta, Peyush Bansal, Anupam Mittal & Vineeta Singh
₹1.5 Cr for 2%
After the show
We have not found a reliable published report on whether this investment closed after filming.
Company timeline
27 Feb 2023
Pitched on Shark Tank India Season 2, episode 41
Founders & leadership
Agragesh Ramani
Co-founder & CEO
Sources
- 1.Trunome On Shark Tank India Season 2: Learn What The Sharks Had To Offer!
ReadersFusion · Published 1 Mar 2023 · Accessed 21 Oct 2026Recap blog / aggregator
- 2.Trunome has raised INR 1.5 crores from Shark Tank 2.0
Wext · Published 2 Mar 2023 · Accessed 21 Oct 2026Recap blog / aggregator
- 3.Shark Tank India: Trunome Complete Review
Shark Tank India In Hindi · Published 27 Feb 2023 · Accessed 21 Oct 2026Recap blog / aggregator
- 4.Shark Tank India season 2
Wikipedia · Accessed 21 Oct 2026Encyclopedia (lead only)
Spotted something wrong?
Corrections with a source link are reviewed and applied to the dataset.